amifostine anhydrous has been researched along with Leukemia P388 in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Green, D | 1 |
| Bensely, D | 1 |
| Schein, P | 1 |
1 other study available for amifostine anhydrous and Leukemia P388
| Article | Year |
|---|---|
Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
Topics: Administration, Oral; Amifostine; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Bo | 1994 |